(Q39666134)

English

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies

scientific article published on 10 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies (English)

1 reference

Europe PubMed Central

13 September 2017

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

M Braun

1

1 reference

Europe PubMed Central

13 September 2017

D Goltz

2

1 reference

Europe PubMed Central

13 September 2017

Z Shaikhibrahim

3

1 reference

Europe PubMed Central

13 September 2017

W Vogel

4

1 reference

Europe PubMed Central

13 September 2017

D Böhm

5

1 reference

Europe PubMed Central

13 September 2017

V Scheble

6

1 reference

Europe PubMed Central

13 September 2017

K Sotlar

7

1 reference

Europe PubMed Central

13 September 2017

F Fend

8

1 reference

Europe PubMed Central

13 September 2017

S-H Tan

9

1 reference

Europe PubMed Central

13 September 2017

A Dobi

10

1 reference

Europe PubMed Central

13 September 2017

G Kristiansen

11

1 reference

Europe PubMed Central

13 September 2017

N Wernert

12

1 reference

Europe PubMed Central

13 September 2017

S Perner

13

1 reference

Europe PubMed Central

13 September 2017

publication date

10 January 2012

1 reference

Europe PubMed Central

13 September 2017

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

13 September 2017

15

1 reference

Europe PubMed Central

13 September 2017

2

1 reference

Europe PubMed Central

13 September 2017

165-169

1 reference

Europe PubMed Central

13 September 2017

https://scigraph.springernature.com/pub.10.1038/pcan.2011.67

0 references

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ETS gene fusions in prostate cancer: from discovery to daily clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ETS gene fusions in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ERG gene rearrangements are common in prostatic small cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ERG rearrangement in small cell prostatic and lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ERG rearrangement metastasis patterns in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Antibody-based detection of ERG rearrangement-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Delineation of TMPRSS2-ERG splice variants in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Ets family protein, erg expression in developing and adult mouse tissues by a highly specific monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ERG rearrangement is present in a subset of transition zone prostatic tumors

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.67

21 January 2018

Identifiers

10.1038/PCAN.2011.67

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39666134&oldid=1856136680"